CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Topical Cantharidin/ Salicylic Acid/ Podophyllin for the Treatment of Warts: Clinical Effectiveness and Guidelines

Last updated: January 21, 2019
Project Number: RA1006-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report

Question

  1. What is the comparative clinical effectiveness of topical cantharidin/salicylic acid/podophyllin versus other topical treatments for warts?
  2. What are the evidence-based guidelines for the topical treatment of warts?

Key Message

One non-randomized study and two evidence-based guidelines were identified regarding topical cantharidin/ salicylic acid/ podophyllin for the treatment of warts.